Loading Valuation Snapshot...
Stock DNA
Hospital & Healthcare Services
INR 5 Cr (Micro Cap)
5.00
55
0.00%
0.11
6.50%
0.53
Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - )
Net Profit:
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-42.68%
0%
-42.68%
1 Year
-46.35%
0%
-46.35%
2 Years
-58.64%
0%
-58.64%
3 Years
-67.81%
0%
-67.81%
4 Years
-15.47%
0%
-15.47%
5 Years
28.98%
0%
28.98%
Dr Lalchand. Lab for the last several years.
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.80%
EBIT Growth (5y)
-1.65%
EBIT to Interest (avg)
0.93
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.94
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.97%
ROE (avg)
11.59%
Valuation key factors
Factor
Value
P/E Ratio
5
Industry P/E
55
Price to Book Value
0.53
EV to EBIT
6.12
EV to EBITDA
4.40
EV to Capital Employed
0.58
EV to Sales
1.27
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
7.28%
ROE (Latest)
6.50%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Arjan Lal Chandani (51.48%)
Highest Public shareholder
Amit Charan (5.08%)
Individual Investors Holdings
36.54%
Half Yearly Results Snapshot (Standalone) - Sep'24
Sep'24
Mar'24
Change(%)
Net Sales
2.13
2.08
2.40%
Operating Profit (PBDIT) excl Other Income
0.54
1.03
-47.57%
Interest
0.05
0.28
-82.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.15
0.71
-78.87%
Operating Profit Margin (Excl OI)
25.35%
49.52%
-24.17%
Values in Rs Cr.
Net Sales
Growth in half year ended Sep 2024 is 2.40% vs -23.81% in Mar 2024
Standalone Net Profit
Growth in half year ended Sep 2024 is -78.87% vs 888.89% in Mar 2024
Annual Results Snapshot (Standalone) - Mar'24
Mar'24
Mar'23
Change(%)
Net Sales
4.81
5.04
-4.56%
Operating Profit (PBDIT) excl Other Income
1.39
0.09
1,444.44%
Interest
0.38
0.99
-61.62%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.62
-1.56
139.74%
Operating Profit Margin (Excl OI)
28.90%
1.79%
27.11%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2024 is -4.56% vs -55.32% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 139.74% vs -267.74% in Mar 2023
About Dr Lalchandani Labs Ltd 
Dr Lalchandani Labs Ltd
Micro Cap
Hospital & Healthcare Services
Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of "Dr.
Company Coordinates 
Company Details
M-20 Basement, Greater Kailash-1 New Delhi New Delhi : 110048
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai